Effects of TNF Secreting HEK Cells on B Lymphocytes' Apoptosis in Human Chronic Lymphocytic Leukemias |
Valizadeh, Armita
(Department of Anatomy, School of Medicine, Ahvaz Jundishapur University of Medical Sciences)
Ahmadzadeh, Ahmad (Thalassemia and Hemoglobinopathies Research Center, Shafa Hospital, Ahvaz Jundishapur University of Medical Sciences) Teimoori, Ali (Virology Department, Ahvaz Jundishapur University of Medical Sciences) Khodadadi, Ali (Cancer, Petroleum and Environmental Pollutants Research Center, Ahvaz Jundishapur University of Medical Sciences) Saki, Ghasem (Department of Anatomy, School of Medicine, Ahvaz Jundishapur University of Medical Sciences) |
1 | Ashkenazi A, Pai RC, Fong S, et al (1999). Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest, 104, 155-62. DOI ScienceOn |
2 | Chen FC, Zhang F, Zhang ZJ, et al (2013). Tumor necrosis factor- gene polymorphisms and risk of oral cancer: evidence from a meta-analysis. Asian Pac J Cancer Prev, 14, 7243-9. 과학기술학회마을 DOI |
3 | Choi SA, Hwang SK, Wang KC, et al (2011). Therapeutic efficacy and safety of TRAIL producing human adipose tissue - derived mesenchymal stem cells against experimental brainstem glioma. Neuro-Oncol, 13, 61- 9. DOI |
4 | Duiker EW, Mom CH, de Jong S, et al (2006). The clinical trail of TRAIL. Eur J Cancer, 42, 2233-40. DOI ScienceOn |
5 | Grisendi G, Bussolari R, Cafarelli L, et al (2010). Adiposederived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. Cancer Res, 70, 3718-29. DOI |
6 | HengXu, Yan-Na Tian, Bo-Ying Dun, et al (2014). A Novel Monoclonal Antibody Induces Cancer Cell Apoptosis and Enhances the Activity of Chemotherapeutic Drugs. Asian Pac J Cancer Prev, 15, 4423-8. 과학기술학회마을 DOI |
7 | Jiang L, Hao JL, Jin ML,et al (2013). Effect of embelin on TRAIL receptor 2 mAb-induced apoptosis of TRAIL-resistant A549 non-small cell lung cancer cells. Asian Pac J Cancer Prev, 14, 6115-20. 과학기술학회마을 DOI ScienceOn |
8 | Kay NE, Shanafelt TD, Strege AK, et al (2007). Bone biopsy derived marrow stromalelements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced celldeath and facilitates an “angiogeneic switch”. Leuk Res, 31, 899-906. DOI |
9 | Kim SM, Lim JY, Park SI, et al (2008). Gene therapy using TRAIL-secreting human umbilical cord blood derived mesenchymal stem cells against intracranial glioma. Cancer Res, 68, 9614-23. DOI |
10 | Lagneaux L, Delforge A, Bron D, et al (1998). Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood, 91, 2387-96. |
11 | Loebinger MR, Eddaoudi A, Davies D, et al (2009). Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer. Cancer Res, 69, 4134-42. |
12 | Mahalingam D, Szegezdi E, Keane M, et al (2009). TRAIL receptor signalling and modulation: Are we on the right TRAIL? Cancer Treat Rev, 35, 280-8. DOI ScienceOn |
13 | Messmer BT, Messmer D, Allen SL, et al (2005). In vivomeasurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J Clin Invest, 115, 755-64. DOI |
14 | Montserrat E (2002).Current and developing chemotherapy for CLL. Med Oncol.19, 11-19. DOI |
15 | Nwabo Kamdje AH, Bassi G, PacelliL, et al (2012). Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy. Blood Cancer Journal, 2, 73 DOI |
16 | Panayiotidis P, Jones D, Ganeshaguru K, et al (1996). Human bone marrow stromal cellsprevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro. Br J Haematol, 92, 97-103. DOI |
17 | SeiffertM, SchulzA, Ohl S, et al (2010). Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo. Blood, 116, 4223-30. DOI |
18 | Wiley SR, Schooley K, Smolak PJ, et al (1995). Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity, 3, 673-82. DOI ScienceOn |
19 | Sprick MR, Weigand MA, Rieser E, et al (2000). FADD/MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2. Immunity, 12, 599-609. DOI ScienceOn |
20 | Walczak H, Miller RE, Ariail K, et al (1999). Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand In vivo. Nat Med, 5, 157-63. DOI ScienceOn |
21 | Zhao B, Li L, Cui K, et al (2011). Mechanisms of TRAIL and gemcitabine induction of pancreatic cancer cell apoptosis. Asian Pac J Cancer Prev, 12, 2675-8. |